Comparison of combined intranasal dexmedetomidine and ketamine versus chloral hydrate for pediatric procedural sedation: a randomized controlled trial
Korean Journal of Anesthesiology · 01.06.2025 · 78 (3) · 248-260
DOI: 10.4097/kja.24815 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Korean Journal of Anesthesiology, erschienen am 01.06.2025. Verfasst von Young-Eun Jang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Dexmedetomidine, Ketamine, Hypnotics and Sedatives, Chloral Hydrate. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Patient-Centered Clinical Research Coordinating Center, Ministry of Health and Welfare.
Abstract (Originalsprache)
Background
We hypothesized that intranasal combination of dexmedetomidine (2 μg/kg) and ketamine (3 mg/kg) (IN DEXKET) improves the success rate of sedation in pediatric patients compared with chloral hydrate (CH; 50 mg/kg).
Methods
This prospective, two-center, single-blinded, randomized controlled trial involved 136 pediatric patients (aged < 7 years) requiring procedural sedation. The participants were randomized to receive CH or IN DEXKET via a mucosal atomizer device. The primary outcome was the success rate of sedation (Pediatric Sedation State Scale, scores 1–3) within 15 min. The secondary outcomes included sedation failure at 30 min and overall complications of first-attempt sedation.
Results
After excluding eight patients, 128 were included (CH = 66, IN DEXKET = 62). IN DEXKET showed a similar sedation success rate (75.8% [47/62] vs. 66.7% [44/66]; P = 0.330) but a lower complication rate (3.2% [2/62] vs. 16.7% [11/66]; P = 0.017) than CH. In the subgroup analysis for patients aged < 1 year, IN DEXKET showed a reduced complication rate than CH (2.6% [1/38] vs. 22.9% [8/35]; P = 0.012). In the subgroup analysis of children aged 1–7 years, IN DEXKET showed a higher sedation success rate within 15 min (79.2% [19/24] vs. 51.6% [16/31]; P = 0.049) and a lower sedation failure after 30 min (0% vs. 29.0% [9/31]; P = 0.003) than CH.
Conclusions
The intranasal combination of dexmedetomidine (2 μg/kg) and ketamine (3 mg/kg) is a safe and effective alternative to CH (50 mg/kg) for sedation in pediatric patients aged < 7 years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
- Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Förderung
- Patient-Centered Clinical Research Coordinating Center
- Ministry of Health and Welfare
Zitieren
APA
Jang, Y. E., Joo, E. Y., Park, J. B., Ji, S. H., Kim, E. H., Lee, J. H., Kim, H. S., & Kim, J. T. (2025). Comparison of combined intranasal dexmedetomidine and ketamine versus chloral hydrate for pediatric procedural sedation: a randomized controlled trial. Korean Journal of Anesthesiology, 78(3), 248-260. https://doi.org/10.4097/kja.24815
Vancouver
Jang YE, Joo EY, Park JB, Ji SH, Kim EH, Lee JH, et al. Comparison of combined intranasal dexmedetomidine and ketamine versus chloral hydrate for pediatric procedural sedation: a randomized controlled trial. Korean Journal of Anesthesiology. 2025;78(3):248-260. doi:10.4097/kja.24815
BibTeX
@article{Jang2025,
author = {Jang, Young-Eun and Joo, Eun-Young and Park, Jung-Bin and Ji, Sang-Hwan and Kim, Eun-Hee and Lee, Ji-Hyun and Kim, Hee-Soo and Kim, Jin-Tae},
title = {Comparison of combined intranasal dexmedetomidine and ketamine versus chloral hydrate for pediatric procedural sedation: a randomized controlled trial},
journal = {Korean Journal of Anesthesiology},
year = {2025},
volume = {78},
number = {3},
pages = {248--260},
doi = {10.4097/kja.24815}
}
EUVIMED